AAAAAA

   
Results: 1-7 |
Results: 7
PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT
Authors: ROWINSKY EK LONG GS NOE DA GROCHOW LB BOWLING MK SARTORIUS SE DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF CI-980, A NOVEL SYNTHETIC ANTIMICROTUBULE AGENT, Clinical cancer research, 3(3), 1997, pp. 401-407
A PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN INFUSED OVER 30 MINUTES FOR 5 DAYS IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA
Authors: ROWINSKY EK KAUFMANN SH BAKER SD MILLER CB SARTORIUS SE BOWLING MK CHEN TL DONEHOWER RC GORE SD
Citation: Ek. Rowinsky et al., A PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN INFUSED OVER 30 MINUTES FOR 5 DAYS IN PATIENTS WITH REFRACTORY ACUTE-LEUKEMIA, Clinical cancer research, 2(12), 1996, pp. 1921-1930
PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS
Authors: ROWINSKY EK GROCHOW LB SARTORIUS SE BOWLING MK KAUFMANN SH PEEREBOOM D DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDY OF HIGH-DOSES OF THE TOPOISOMERASE-I INHIBITOR TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 14(4), 1996, pp. 1224-1235
SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE
Authors: ROWINSKY EK KAUFMANN SH BAKER SD GROCHOW LB CHEN TL PEEREBOOM D BOWLING MK SARTORIUS SE ETTINGER DS FORASTIERE AA DONEHOWER RC
Citation: Ek. Rowinsky et al., SEQUENCES OF TOPOTECAN AND CISPLATIN - PHASE-I, PHARMACOLOGICAL, AND IN-VITRO STUDIES TO EXAMINE SEQUENCE DEPENDENCE, Journal of clinical oncology, 14(12), 1996, pp. 3074-3084
PHASE-I AND PHARMACOLOGICAL STUDIES OF PYRAZOLOACRIDINE, A NOVEL DNA INTERCALATING AGENT, ON SINGLE-DOSING AND MULTIPLE-DOSING SCHEDULES
Authors: ROWINSKY EK NOE DA GROCHOW LB SARTORIOUS SE BOWLING MK CHEN TL LUBEJKO BG KAUFMANN SH DONEHOWER RC
Citation: Ek. Rowinsky et al., PHASE-I AND PHARMACOLOGICAL STUDIES OF PYRAZOLOACRIDINE, A NOVEL DNA INTERCALATING AGENT, ON SINGLE-DOSING AND MULTIPLE-DOSING SCHEDULES, Journal of clinical oncology, 13(8), 1995, pp. 1975-1984
PRETREATMENT H-2-RECEPTOR ANTAGONISTS THAT DIFFER IN P450 MODULATION ACTIVITY - COMPARATIVE EFFECTS ON PACLITAXEL CLEARANCE RATES AND NEUTROPENIA
Authors: SLICHENMYER WJ DONEHOWER RC CHEN TL BOWLING MK MCGUIRE WP ROWINSKY EK
Citation: Wj. Slichenmyer et al., PRETREATMENT H-2-RECEPTOR ANTAGONISTS THAT DIFFER IN P450 MODULATION ACTIVITY - COMPARATIVE EFFECTS ON PACLITAXEL CLEARANCE RATES AND NEUTROPENIA, Cancer chemotherapy and pharmacology, 36(3), 1995, pp. 227-232
PHASE-I STUDY OF PACLITAXEL AS A 3-HOUR INFUSION FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
Authors: ROWINSKY EK FLOOD WA SARTORIUS SE BOWLING MK WAGNER J ETTINGER DS
Citation: Ek. Rowinsky et al., PHASE-I STUDY OF PACLITAXEL AS A 3-HOUR INFUSION FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Seminars in oncology, 22(4), 1995, pp. 48-54
Risultati: 1-7 |